Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

Abstract Background Critically ill coronavirus disease 2019 (COVID-19) patients have a high risk of acute kidney injury (AKI) that requires renal replacement therapy (RRT). A state of hypercoagulability reduces circuit life spans. To maintain circuit patency and therapeutic efficiency, an optimized...

Full description

Bibliographic Details
Main Authors: Frederic Arnold, Lukas Westermann, Siegbert Rieg, Elke Neumann-Haefelin, Paul Marc Biever, Gerd Walz, Johannes Kalbhenn, Yakup Tanriver
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Nephrology
Subjects:
COVID-19
SARS-CoV-2
Acute kidney injury
Renal replacement therapy
Anticoagulation
Critical care
Online Access:http://link.springer.com/article/10.1186/s12882-020-02150-8

Internet

http://link.springer.com/article/10.1186/s12882-020-02150-8

Similar Items